Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Recurrence × Erlotinib Hydrochloride × Clear all

Phase

Phase 2 3 Phase NA 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 5 Neoplasms 3 Recurrence 1 Pancreatic Neoplasms 1 Oligometastatic Lung Adenocarcinoma 1 Neoplasm Metastasis 1 NSCLC 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Glioma 1 Gastrointestinal Neoplasms 1 EGFR Mutation Positive Non-small Cell Lung Cancer 1 Carcinoma 1 Breast Neoplasms 1

Interventions

Radiotherapy 10 fludarabine phosphate 9 Peripheral Blood Stem Cell Transplantation 8 Cyclosporine 7 Cyclophosphamide 7 Busulfan 7 Whole-Body Irradiation 6 Melphalan 6 Radiofrequency Ablation 5 Mycophenolic Acid 5 Filgrastim 5 Antilymphocyte Serum 5 Surveys and Questionnaires 4 Surgical Procedures, Operative 4 Methotrexate 4 Etoposide 4 Drug Therapy 4 Cisplatin 4 fludarabine 3 Radiosurgery 3 Injections 3 Hepatectomy 3 Cord Blood Stem Cell Transplantation 3 thymoglobulin 2 lenvatinib 2 Vinblastine 2 Videotape Recording 2 Thiotepa 2 Standard of Care 2 Sorafenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02015728 2016-12-15

SEED

Seattle Children's Hospital

Phase NA Unknown

Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡